ProgStar Research Group

Stargardt Disease Study Sponsored by FFB


Study News

Stargardt Disease

Stargardt Diseased Eye

Stargardt Disease (STGD) is the most prevalent form of juvenile-onset macular dystrophy, predominantly due to gene mutations in an autosomal Read More…



On this page you will find a list of current ProgStar publications as well as previous publications relevant to STGD by current ProgStar study investigators. Read More …

About the Study

Study Worker

Sponsored by the Foundation Fighting Blindness, the Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies Read More…

Progstar's Mission

  • To determine the best outcome measures to accelerate evaluation of emerging treatments.
  • To better understand disease progression for selecting future clinical trial participants.
  • To identify potential participants for forthcoming clinical trials.
  • To establish technology, trial sites, Reading Center, and patient cohorts.